An observational study in ELBW - Extremely Low Birth Weight Infant and IVH- Intraventricular Hemorrhage, sponsored by Rambam Health Care Campus. Completed at 1 site in Israel. Open to participants aged 0 Minutes to 24 Hours. Per ClinicalTrials.gov, last updated 2022-04-28.
Sponsored by Rambam Health Care Campus · Observational
An observational study comparing outcomes of Extremely Low Birth Weight (ELBW) infants that were monitored with non-invasive Transcutaneous CO2 (TCCO2) monitor to infants that were not monitored by TCCO2 monitor.
ELBW infants
Exclusion Criteria:
TCCO2 monitoring
Routine monitoring
IVH-Intraventricular Hemorrhage
Intraventricular Hemorrhage
Time frame: Repeated scans until infant reaches corrected age of 42 weeks
PVL- Periventricular Leukomalacia
Periventricular Leukomalacia
Time frame: Repeated scans until infant reaches corrected age of 42 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rambam Health Care Campus